Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Empagliflozin/metoprolol

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Seto J, et al. MAVACAMTEN USE AS AN ALTERNATIVE TO CARDIAC TRANSPLANTATION IN A PATIENT WITH END STAGE HEART FAILURE SECONDARY TO SEVERE APICAL HCM. Journal of the American College of Cardiology 83 (Suppl.): 2822, No. 13, Apr 2024. Available from: URL: https://dx.doi.org/10.1016/S0735-1097%2824%2904812-5 [abstract] Seto J, et al. MAVACAMTEN USE AS AN ALTERNATIVE TO CARDIAC TRANSPLANTATION IN A PATIENT WITH END STAGE HEART FAILURE SECONDARY TO SEVERE APICAL HCM. Journal of the American College of Cardiology 83 (Suppl.): 2822, No. 13, Apr 2024. Available from: URL: https://​dx.​doi.​org/​10.​1016/​S0735-1097%2824%2904812-5 [abstract]
Metadaten
Titel
Empagliflozin/metoprolol
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56827-3

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Fluorouracil

Case report

Multiple drugs

Case report

Multiple drugs